Items where authors include "Harbeck, B."

Article

Prete, A. orcid.org/0000-0002-4821-0336, Theiler-Schwetz, V. orcid.org/0000-0002-2378-689X, Arlt, W. et al. (13 more authors) (2026) Effects of modified release hydrocortisone on restoration of early morning cortisol, quality of life, and fatigue in adrenal insufficiency (The CHAMPAIN study): a randomised, double-blind, double-dummy, cross-over study comparing Chronocort and Plenadren. eClinicalMedicine, 91. 103714. ISSN 2589-5370

Proceedings Paper

Prete, A., Theiler-Schwetz, V., Arlt, W. et al. (12 more authors) (2025) OR07-08 A double-blind study of modified-release hydrocortisones, chronocort versus plenadren, in adrenal insufficiency (CHAMPAIN). In: Journal of the Endocrine Society. ENDO 2025 Annual Meeting of the Endocrine Society, 12-15 Jul 2025, San Francisco, USA. Oxford University Press (OUP) .

Prete, A., Theiler-Schwetz, V., Arlt, W. et al. (13 more authors) (2024) 12670 CHAMPAIN study: initial results from a phase II study of efficacy, safety and tolerability of modified-release hydrocortisones: Chronocort® (Efmody®) versus Plenadren®, in primary adrenal insufficiency. In: Journal of the Endocrine Society. ENDO 2024 Abstracts Annual Meeting of the Endocrine Society, 01-04 Jun 2024, Boston, USA. The Endocrine Society .

Prete, A., Theiler-Schwetz, V., Arlt, W. et al. (13 more authors) (2024) 7692 Morning cortisol levels in patients with established primary adrenal insufficiency. In: Journal of the Endocrine Society. ENDO 2024 Abstracts Annual Meeting of the Endocrine Society, 01-04 Jun 2024, Boston, USA. The Endocrine Society .

Prete, A., Theiler-Schwetz, V., Arlt, W. et al. (13 more authors) (2024) 9341 CHAMPAIN Study: Initial results from a phase II study of efficacy, safety and tolerability of modified-release hydrocortisones: Chronocort® (Efmody®) versus Plenadren®, in primary adrenal insufficiency. In: Journal of the Endocrine Society. ENDO 2024 Abstracts Annual Meeting of the Endocrine Society, 01-04 Jun 2024, Boston, USA. The Endocrine Society .